One GLP-1 response variant became 229 new hypotheses worth testing We analyzed 2,734 DNA changes around GLP1R and found hundreds predicted to have larger effects, including rare variants that population studies may miss This is the opportunity for genomic AI: turning overlooked DNA into testable biology across drugs and diseases genomicintelligence.ai/blog/… #GLP1 #GenomicAI #DrugDiscovery

Why does Ozempic work better for some people than others? A Nature study linked a GLP1R variant to greater weight loss. Our genomic models suggest a second mechanism: the variant may affect not only how the receptor works, but also how much of it the body produces. We then screened rare variants that GWAS can miss—collectively carried by an estimated 527M people worldwide. This is what genomic AI makes possible: moving from population-level association to individual, testable biological hypotheses. Read the study and try the workflow on your own genome: genomicintelligence.ai/blog/… #Genomics #GLP1 #PrecisionMedicine #AIforScience

The genome is becoming programmable through natural language We partnered with @PhyloBio to bring @GenomeLayer models into Biomni Lab so researchers can move from a biological question to regulatory DNA analysis, expression prediction, variant interpretation, and sequence optimization inside one agentic workflow Try it yourself ↓ genomicintelligence.ai/blog/… #AIForScience #Genomics #Biotech